期刊文献+

RhoE对cd44基因启动子的转录活性及大肠癌细胞系恶性生物学行为的影响 被引量:2

The Affect of RhoE on cd44 Promoter and the Malignant Behaviors of Colorectal Cancer Cell
原文传递
导出
摘要 目的研究RhoE对cd44基因启动子的转录调控,并探讨RhoE对裸鼠体内成瘤性的影响。方法采用PCR技术从人胚肾HEK293细胞中扩增出cd44启动子,并将其插入荧光素酶报告基因载体pGL3-Basic中,经测序确定所扩增的DNA序列,并将其转染入SW480及LoVo细胞中监测其活性。将pcDNA3.1-RhoE和pcDNA3.1分别与pGL3-CD44 promoter共转染大肠癌LoVo细胞和SW480细胞,双荧光素报告基因检测活性。另外将pcDNA3.1-RhoE和对照组分别稳定转染LoVo细胞和SW480细胞,并将筛选的稳定表达的细胞分别接种裸鼠,观察肿瘤的生长;用免疫组化的方法检测RhoE对肿瘤组织细胞形态及CD44分子表达的影响。结果测序结果表明,扩增的cd44启动子序列正确,双报告基因实验检测荧光素酶活力表明构建的报告基因具有启动子活性。含cd44启动子序列的报告基因在pcDNA3.1-RhoE阳性的LoVo细胞中表达受到抑制;HE染色显示pcDNA3.1-RhoE转染组较对照组肿瘤细胞明显变小,且大小和形态呈现一致性,已没有瘤巨细胞,相应的肿瘤细胞核的体积也变小。结论 RhoE通过抑制cd44基因启动子的活性部分逆转肿瘤的恶性生物学行为。为研究RhoE表达与cd44基因的关系及CD44蛋白表达与结直肠癌发生、发展及浸润转移的关系提供了良好的实验基础。 Objective To study the effect of RhoE on the transcriptional regulation of cd44 and in vivo tumorigenicity of nude mice.Methods cd44 promoter was amplified from human embryonic kidney HEK293 cells with PCR and insert into Dual-Luciferase○R Reporter plasmid pGL3-Basic.After confirmed with sequence analysis,the generated recombinant was transfected into SW480 and LoVo cells to monitor their activity.Colon cancer SW480 and LoVo cells were cotransfected with pGL3-CD44 promoter along with pcDNA3.1-RhoE and pcDNA3.1 respectively.SW480 and LoVo cells were stably transfected with pcDNA3.1-RhoE and the control group and were inoculated into nude mice to observe tumor growth.Immunohistochemistry assay was applied to observe the morphology of tumor cells and the expression of CD44 molecules.Results The cd44 promoter sequence was amplified correctly,Dual-Luciferase○R Reporter Assay showed that the constructed reporter gene has promoter activity.The expression of cd44 promoter sequence containing reporter gene in pcDNA3.1-RhoE expression positive LoVo cells was inhibited;HE staining demonstrated that the pcDNA3.1-RhoE transfected tumor cells was significantly smaller than that in the control group,and consistent size and shape tumor cells were observed but no tumor giant cells,the corresponding volume of the tumor nuclei were also small.Conclusion RhoE could partially reverse the malignant biological behavior of tumors by inhibiting the transcriptional regulation of cd44 promoter.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2011年第5期589-593,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(批准号81071640 30901719及30971519)资助
关键词 cd44启动子 RHOE 荧光素酶报告基因 体内成瘤 cd44 promoter RhoE Dual-luciferase reporter gene Tumorigenicity
  • 相关文献

参考文献11

  • 1Harada N, MizoiT. Kinouchi M. et al. Introduction of anusense CD44s cDNA down-regulates expression of overall CD44 isoforms and inhihits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer, 2001 ; 91 ( 1 ) :67-75.
  • 2Wielcnga VJ, Heider KH, OfferhausGJ, etal. Expression of CD4,t variant proleins in human colorectal cancer is related to tumor progression. Cancer Res, 1993 , 53 ( 20 ) :4754-4756.
  • 3Bourguignon I.Y. Singleton PA, Zhu H, et al. Hyaluronan- mediated CD44 inleraclion wida RhoGEF and Rho kinase promotes Grb2-associated hinder- 1 phosphorylation and phosphatidylinosilol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast lumor progression. J Biol Chem,2003;278(32):294202943,1.
  • 4Guo YJ, Liu GL. Wang XN, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in palients wit h gast ric or colon cancer. Cancer Res, 1994 ; 54 ( 1 ) : 422-426.
  • 5Nobes CD, Lauritzen I, Mattei MG, et al. A new member of the Rho family, Rndl, promolt's disassembly of actin filament slruclures and loss of cell adhesion. J Cell Biol. 1998, 141 ( 1 ) : 187-197.
  • 6Beklic J, Pfeil K, Berger AP, et al. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoplosis. Prostate. 2005, 64 ( 4 ) : 332-340.
  • 7朱亚杰,石芳,张思源,罗德云,邱萌,李志平,金伯泉,毕锋.RhoE在胃肠道肿瘤组织中的表达及其临床意义[J].现代肿瘤医学,2008,16(6):989-992. 被引量:3
  • 8Liu N, Bi F, Pan Y, et al. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity, Clin Cancer Res, 2004 , 10( 18 Pt 1 ) :6239-6247.
  • 9Talens-Viscomi R, Peris B, Guerri Co et al. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-1 signalling. J Neurochem, 2010; 112 ( 4 ) : 1074- 1087.
  • 10Poeh E, Miambres R, Mocholi E, et al. RhoE interferes with Rb inactivation and regulates the proliferation and survival of thc U87 human glioblastorna cell line. Exp Cell Res, 2007 ; 313 (4) :719-731.

二级参考文献17

  • 1Ridley AJ. Rho family proteins: coordinating cell responses [ J ]. Trends Cell Biol, 2001, 11(12) : 471 -477.
  • 2Burridge K, Wennerberg K. Rho and Rac take center stage [J]. Cell, 2004, 116(2) :167 - 179.
  • 3Foster R, Hu K Q, Lu Y, et al. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation[ J]. Mol Cell Biol, 1996,16 : 2689 - 2699.
  • 4Nobes CD, Lauritzen I, Mattei MG, et al. A new member of the Rho family, Rndl, promotes disassembly of actin filament structures and loss of cell adhesion[J]. J Cell Biol, 1998,141 : 187 - 197.
  • 5Guasch RM, Scambler P, Jones GE, et al. RhoE regulates actin cytoskeleton organization and cell migration [ J ]. Mol Cell Biol, 1998,18 : 4761 -4771.
  • 6Etienne -Manneville S, Hall A. Rho GTPases in cell biology[J]. Nature, 2002, 420 (6916): 629- 635.
  • 7Boettner B, Van Aelst L. The role of Rho GTPases in disease development[J]. Gene, 2002, 286(2): 155- 174.
  • 8Liu N, Bi F, Pan Y, et al. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity [J]. Clin Cancer Res, 2004, 10 (18 Pt 1): 6239-6247.
  • 9Sahai E, Marshall CJ. RHO- GTPases and cancer[J]. Nat Rev Cancer, 2002, 2(2):133-142.
  • 10Riento K, Guasch RM, Garg R, et al. RhoE binds to ROCK Ⅰ and inhibits downstream signaling[ J]. Mol Cell Biol, 2003,23: 4219 - 4229.

共引文献2

同被引文献22

  • 1Haynes B F,Liao H X,Patton K L.The transmembrane hyaluronate receptor (CD44):multiple functions,multiple forms[J].Cancer Cells,1991,3:347-350.
  • 2Jothy S.CD44 and its partners in metastasis[J].Clin Exp Metastasis,2003,20(3):195-201.
  • 3Xiang Q,He X,Fan C,et al.Homo sapiens CD44 variant mRNA,complete cds,alternatively spliced.GenBank accession No:EF581837.
  • 4Misra S,Heldin P,Hascall V C,et al.HyaluronanCD44 interactions as potential targets for cancer therapy[J].FEBS J,2011,278(9):1429-1443.
  • 5Wang S J,Bourguignon L Y.Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance[J].Am J Pathol,2011,178 (3):956-963.
  • 6Eleonor Olsson,Gabriella Honeth,P(a)r-Ola Bendahl,et al.CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers[J].BMC Cancer,2011,11:418.
  • 7Jang B I,Li Y,Graham D Y,et al.The Role of CD44 in the pathogenesis,diagnosis,and therapy of gastric cancer[J].Gut Liver,2011,5(4):397-405.
  • 8Kopp R,Fiehter M,Schalhorn G,et al.Frequent expression of the high molecular,673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas[J].Int J Mol Med,2009,24(5):677-683.
  • 9Wang S J,Wong G,de Heer A M,et al.CD44 variant isoforms in head and neck squamous cell carcinoma progression[J].Laryngoscope,2009,119(8):1518-1530.
  • 10Weber G F,Bronson R T,Lagan J,et al.Absence of the CD44 gene prevents sarcoma metastasis[J].Cancer Res,2002,62(8):2281-2286.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部